These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 25499722

  • 1. The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.
    Tucker DK, Macon MB, Strynar MJ, Dagnino S, Andersen E, Fenton SE.
    Reprod Toxicol; 2015 Jul; 54():26-36. PubMed ID: 25499722
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice.
    Zhao Y, Tan YS, Strynar MJ, Perez G, Haslam SZ, Yang C.
    Reprod Toxicol; 2012 Jul; 33(4):563-576. PubMed ID: 22414604
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice.
    Zhao Y, Tan YS, Haslam SZ, Yang C.
    Toxicol Sci; 2010 May; 115(1):214-24. PubMed ID: 20118188
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains.
    Yang C, Tan YS, Harkema JR, Haslam SZ.
    Reprod Toxicol; 2009 Jun; 27(3-4):299-306. PubMed ID: 19013232
    [Abstract] [Full Text] [Related]

  • 9. Does developmental exposure to perflurooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders?
    Hu Q, Franklin JN, Bryan I, Morris E, Wood A, DeWitt JC.
    Neurotoxicology; 2012 Dec; 33(6):1491-1498. PubMed ID: 23137609
    [Abstract] [Full Text] [Related]

  • 10. Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.
    Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Fenton SE, Lindstrom AB, Strynar MJ.
    Reprod Toxicol; 2009 Jun; 27(3-4):360-364. PubMed ID: 19028561
    [Abstract] [Full Text] [Related]

  • 11. Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups.
    Fenton SE, Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Hines EP, White SS, Lindstrom AB, Strynar MJ, Petropoulou SE.
    Reprod Toxicol; 2009 Jun; 27(3-4):365-372. PubMed ID: 19429407
    [Abstract] [Full Text] [Related]

  • 12. Maternal exposure to perfluorooctanoic acid (PFOA) causes liver toxicity through PPAR-α pathway and lowered histone acetylation in female offspring mice.
    Li D, Zhang L, Zhang Y, Guan S, Gong X, Wang X.
    Environ Sci Pollut Res Int; 2019 Jun; 26(18):18866-18875. PubMed ID: 31062244
    [Abstract] [Full Text] [Related]

  • 13. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures.
    Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, Thibodeaux J, Das KP, White SS, Lau CS, Abbott BD.
    Toxicol Sci; 2007 Feb; 95(2):462-73. PubMed ID: 17098816
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.
    Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE.
    Mol Cell Endocrinol; 2009 May 25; 304(1-2):97-105. PubMed ID: 19433254
    [Abstract] [Full Text] [Related]

  • 15. Effects of perfluorooctanoic acid (PFOA) exposure to pregnant mice on reproduction.
    Yahia D, El-Nasser MA, Abedel-Latif M, Tsukuba C, Yoshida M, Sato I, Tsuda S.
    J Toxicol Sci; 2010 Aug 25; 35(4):527-33. PubMed ID: 20686339
    [Abstract] [Full Text] [Related]

  • 16. Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues.
    Abbott BD, Wood CR, Watkins AM, Tatum-Gibbs K, Das KP, Lau C.
    Reprod Toxicol; 2012 Jul 25; 33(4):491-505. PubMed ID: 22154759
    [Abstract] [Full Text] [Related]

  • 17. Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.
    Filgo AJ, Quist EM, Hoenerhoff MJ, Brix AE, Kissling GE, Fenton SE.
    Toxicol Pathol; 2015 Jun 25; 43(4):558-68. PubMed ID: 25398757
    [Abstract] [Full Text] [Related]

  • 18. Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid.
    van Esterik JC, Bastos Sales L, Dollé ME, Håkansson H, Herlin M, Legler J, van der Ven LT.
    Arch Toxicol; 2016 Mar 25; 90(3):701-15. PubMed ID: 25827101
    [Abstract] [Full Text] [Related]

  • 19. Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors.
    Goulding DR, White SS, McBride SJ, Fenton SE, Harry GJ.
    Neurotoxicology; 2017 Jan 25; 58():110-119. PubMed ID: 27888120
    [Abstract] [Full Text] [Related]

  • 20. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.
    Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ.
    Toxicol Sci; 2006 Apr 25; 90(2):510-8. PubMed ID: 16415327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.